Featured Research

from universities, journals, and other organizations

Internet Program Launched To Prevent Blindness In Diabetic Patients

Date:
July 17, 2005
Source:
Wake Forest University Baptist Medical Center
Summary:
A Wake Forest University Baptist Medical Center team is launching a high-tech study to determine if early screening using a special camera and images transmitted over the Internet can prevent blindness in Medicaid patients with diabetes.

WINSTON-SALEM, N.C. -- A Wake Forest University Baptist Medical Center team is launching a high-tech study to determine if early screening using a special camera and images transmitted over the Internet can prevent blindness in Medicaid patients with diabetes.

"Medicaid patients are rarely screened and are at risk of becoming blind," said Ramon Velez, M.D., M. Sc., the principal investigator. Diabetes is the leading cause of preventable blindness in the United States and Velez said the study will determine if early referral to ophthalmologists will help.

The project -- "I See in NC" -- is being pilot-tested at Downtown Health Plaza of Baptist Hospital, where Velez is medical director, and then will be offered to two rural networks of Community Care of North Carolina. One is Central Piedmont Access II, the other is Access III of the Lower Cape Fear. About 2,000 Medicaid adults with diabetes will be asked to participate.

The other networks of Community Care will get the usual treatment, and Velez and his colleagues will determine whether the screening indeed reduces blindness among patients with diabetic retinopathy because ophthalmologists can act early. Diabetes can lead to changes in blood vessels in the retina called diabetic retinopathy.

Digital photography is the key to the proposal. Trained nurses will take retinal photographs using a special digital camera, and the digital images will be transmitted over the Internet and read at a new screening center at Wake Forest University School of Medicine, Velez said.

The project is being supported by a $465,034 grant from the Duke Endowment to establish the reading center; a $456,203 grant from the Kate B. Reynolds Charitable Trust will pay for the screening in the two networks, and the North Carolina Rural Health Foundation will pay for evaluation.

Velez said Medicaid data would be used to follow the patient outcomes in both the screening group and in the controls.

"Adults with diabetes continue to go blind despite the availability of effective treatment for sight-threatening diabetic retinopathy," said Velez. "These cases of blindness are partially attributable to the low levels of screening. Screening identifies changes in the eye that the patient may not recognize. If treated early, blindness can be prevented."

But, he said, among Medicare patients who have diabetes, more that 30 percent do not get the recommended annual eye screening examination by ophthalmologists. The rate of screening among N.C. Medicaid patients is about 14 percent.

"Primary care physicians rarely perform dilated eye examinations, and the reliability of their examination has been shown to be low," said Velez, a professor of medicine at Wake Forest University School of Medicine and a primary care physician himself. "A recent review of diabetic patients at the Downtown Health Plaza showed that fewer than 20 percent reported having been to an ophthalmologist in the previous three years."

He said that taking retinal photographs in primary care settings is a potential alternative to early testing by ophthalmologists. He said that early trials using film or Polaroid cameras had been effective.

"The recent development of digital retinal photography has spurred a movement to employ this new technology with images transmitted by the Internet to central reading centers," Velez said.

He said that in the pilot testing stage, the team is using a Canon retinal camera, acquired through a grant from the North Carolina Lions Foundation. A diabetic retinopathy reading center is being established at the School of Medicine in cooperation with the Department of Ophthalmology. William P. Moran, M.D., formerly head of the Section on General Internal Medicine, is co-investigator.



Story Source:

The above story is based on materials provided by Wake Forest University Baptist Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Wake Forest University Baptist Medical Center. "Internet Program Launched To Prevent Blindness In Diabetic Patients." ScienceDaily. ScienceDaily, 17 July 2005. <www.sciencedaily.com/releases/2005/07/050716163551.htm>.
Wake Forest University Baptist Medical Center. (2005, July 17). Internet Program Launched To Prevent Blindness In Diabetic Patients. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2005/07/050716163551.htm
Wake Forest University Baptist Medical Center. "Internet Program Launched To Prevent Blindness In Diabetic Patients." ScienceDaily. www.sciencedaily.com/releases/2005/07/050716163551.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins